- Home
- WLAC vs SENS Comparison
WLAC vs SENS Comparison
Compare WLAC & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$6.20
Company Overview
Basic Information| Metric | WLAC | SENS |
|---|---|---|
| Founded | 2024 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.1M | 252.5M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | WLAC | SENS |
|---|---|---|
| Price | $12.18 | $6.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $17.00 | ★ $25.58 |
| AVG Volume (30 Days) | 202.4K | ★ 349.4K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,298,000.00 |
| Revenue This Year | N/A | $59.55 |
| Revenue Next Year | N/A | $70.49 |
| P/E Ratio | $844.52 | ★ N/A |
| Revenue Growth | N/A | ★ 31.94 |
| 52 Week Low | $9.80 | $5.25 |
| 52 Week High | $15.19 | $28.00 |
Technical Indicators
Market Signals| Indicator | WLAC | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 56.71 | 49.91 |
| Support Level | $11.21 | $6.02 |
| Resistance Level | $12.35 | $6.95 |
| Average True Range (ATR) | 0.40 | 0.40 |
| MACD | 0.07 | -0.12 |
| Stochastic Oscillator | 84.65 | 28.78 |
Price Performance
Historical Comparison WLAC
SENS
About WLAC Willow Lane Acquisition Corp. Class A Ordinary Shares
Willow Lane Acquisition Corp is a blank check company.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.